ANIMATION

Vasopressin V2-Receptor Blockage

Share this animation:

Hyponatremia is a condition characterized by low sodium concentration in blood serum. This may be caused by overactivity of anti-diuretic hormone, which results in increased reabsorption of water from the collecting duct. Tolvaptan is an FDA-approved antagonist of the vasopressin V2-receptor. Inhibition of this receptor prevents the expression of aquaporin channels along the collecting duct, promoting diuresis and correcting sodium levels in serum.

Share It:
Contact XVIVO

Client


Otsuka

The art buyer did a great job providing me with several scientific illustrators who I felt could really bring this assignment to life. XVIVO quickly embraced the assignment – made accurate and intelligent suggestions and produced a stunning piece of artwork several days prior to deadline. I look forward to working with them again.

Art Director, DH Art Direction & Design, XCOVERY
Share this animation: